9.2 Endocrine Emergencies
Key Takeaways
- In DKA and HHS management, intravenous fluids are the most critical initial intervention, followed by insulin therapy; however, insulin must be delayed if the serum potassium is < 3.3 mEq/L.
- The Burch-Wartofsky Point Scale is a validated tool to help differentiate impending or actual thyroid storm from uncomplicated thyrotoxicosis based on clinical criteria.
- In thyroid storm, propylthiouracil (PTU) is often preferred over methimazole for acute management because PTU both blocks new thyroid hormone synthesis and inhibits peripheral conversion of T4 to T3.
- In myxedema coma, empiric intravenous glucocorticoids (e.g., hydrocortisone) must be administered before or simultaneously with intravenous levothyroxine to prevent precipitating acute adrenal crisis.
- Acute adrenal crisis typically presents with refractory vasodilatory shock and requires immediate administration of intravenous hydrocortisone (typically 100 mg followed by stress-dose infusions or intermittent boluses).
Endocrine Emergencies in the ICU
Endocrine emergencies can present as profound metabolic derangements and shock. Prompt recognition and protocolized treatment are essential for reducing morbidity and mortality.
Diabetic Ketoacidosis (DKA) and Hyperosmolar Hyperglycemic State (HHS)
Both DKA and HHS are life-threatening complications of diabetes mellitus, characterized by absolute or relative insulin deficiency and an excess of counter-regulatory hormones (glucagon, cortisol, catecholamines, growth hormone).
Pathophysiology and Diagnosis
- DKA: Typically occurs in Type 1 diabetes. Absolute insulin deficiency leads to uninhibited lipolysis, generating free fatty acids that the liver converts into ketone bodies (beta-hydroxybutyrate and acetoacetate). This results in an elevated anion gap metabolic acidosis.
- Diagnostic Criteria: Glucose > 250 mg/dL, arterial pH < 7.30, serum bicarbonate < 18 mEq/L, and positive serum/urine ketones.
- HHS: Typically occurs in Type 2 diabetes. The presence of a small amount of endogenous insulin prevents significant ketogenesis, but severe hyperglycemia leads to profound osmotic diuresis and severe dehydration.
- Diagnostic Criteria: Glucose > 600 mg/dL, arterial pH > 7.30, serum bicarbonate > 18 mEq/L, serum osmolality > 320 mOsm/kg, and absent/minimal ketones.
Management Steps
- Intravenous Fluids: The first and most critical step. Patients have significant fluid deficits (often 3-6 liters in DKA and up to 8-10 liters in HHS). Start with isotonic saline (0.9% NaCl) at 15-20 mL/kg/hr. Once hemodynamically stable, switch to 0.45% NaCl if corrected serum sodium is normal or high.
- Potassium Replacement: Patients have a profound total body potassium deficit, even if the initial serum potassium is high (due to extracellular shift from acidosis and insulin deficiency).
- If K+ is < 3.3 mEq/L: Hold insulin, give IV potassium until K+ > 3.3 mEq/L.
- If K+ is 3.3 - 5.2 mEq/L: Add 20-30 mEq K+ to each liter of IV fluid to keep K+ between 4-5 mEq/L.
- If K+ is > 5.2 mEq/L: Do not give K+, check every 2 hours.
- Insulin Therapy: Start an IV regular insulin infusion at 0.1 Units/kg/hr. Ensure K+ is > 3.3 mEq/L before starting. When blood glucose reaches 200 mg/dL (DKA) or 300 mg/dL (HHS), add dextrose (e.g., D5W) to the IV fluids and decrease the insulin rate to maintain glucose between 150-200 mg/dL until resolution.
- Bicarbonate: The routine use of sodium bicarbonate in DKA is not recommended. It may be considered only for severe acidemia (pH < 6.9) due to the risk of paradoxical intracellular acidosis, hypokalemia, and delayed clearance of ketones.
Thyroid Emergencies
Thyroid Storm
Thyroid storm is a rare, extreme manifestation of thyrotoxicosis with a high mortality rate. It is often precipitated by an acute event (infection, surgery, trauma, iodine load) in a patient with underlying hyperthyroidism.
Diagnosis: The Burch-Wartofsky Point Scale (BWPS) uses clinical criteria (temperature, CNS effects, GI/hepatic dysfunction, heart rate, and heart failure) to assess the likelihood of thyroid storm. A score of 45 or greater is highly suggestive of thyroid storm.
Management (The "5 B's" Concept):
- Block synthesis (Thioamides): Propylthiouracil (PTU) or methimazole. PTU is generally preferred in storm because it blocks both new hormone synthesis and peripheral conversion of T4 to active T3.
- Block release (Iodine): SSKI or Lugol's solution. Must be given at least 1 hour after thioamides to prevent the iodine from being used to synthesize new thyroid hormone.
- Block T4 to T3 conversion (Corticosteroids): High-dose hydrocortisone or dexamethasone prevents peripheral conversion and treats potential relative adrenal insufficiency.
- Beta-blockade: Propranolol is preferred as it controls adrenergic symptoms and also inhibits peripheral T4 to T3 conversion at high doses. Esmolol is an alternative for tighter heart rate control.
- Banish the trigger/supportive care: Treat the underlying infection, aggressive cooling, and fluid resuscitation.
Myxedema Coma
Myxedema coma is the extreme manifestation of severe hypothyroidism, characterized by altered mental status, profound hypothermia, bradycardia, hypotension, and hypoventilation (leading to hypercapnia).
Management:
- Thyroid Hormone Replacement: Intravenous levothyroxine (T4). IV liothyronine (T3) may also be used for faster onset but carries a higher risk of arrhythmias.
- Corticosteroids: Critical step. Empiric IV hydrocortisone (stress dose) must be given before or alongside thyroid hormone. Patients with myxedema coma may have coexisting adrenal insufficiency (Schmidt syndrome) or decreased adrenal reserve; restoring metabolic rate with thyroid hormone without steroids can precipitate acute adrenal crisis.
- Supportive Care: Passive rewarming (active rewarming can cause vasodilation and worsening shock), mechanical ventilation, and IV fluids.
Adrenal Insufficiency and Acute Adrenal Crisis
Acute adrenal crisis is a life-threatening state of severe cortisol deficiency, commonly presenting as refractory distributive (vasodilatory) shock, hypoglycemia, hyponatremia, and hyperkalemia (if primary insufficiency involves aldosterone deficiency).
Primary vs. Secondary:
- Primary (Addison's disease): Adrenal gland destruction. Leads to deficiency of both cortisol and aldosterone (mineralocorticoid). Characterized by hyperpigmentation, hyponatremia, and hyperkalemia.
- Secondary/Tertiary: Pituitary or hypothalamic dysfunction (often due to abrupt cessation of chronic exogenous steroids). Leads to cortisol deficiency, but aldosterone remains intact (regulated by the RAAS system). Potassium is usually normal.
Management:
- Glucocorticoids: Intravenous hydrocortisone (typically 100 mg IV bolus followed by 50 mg IV every 6 hours, or a continuous infusion). Hydrocortisone has both glucocorticoid and mineralocorticoid activity at high doses.
- Fluids: Aggressive resuscitation with normal saline or D5NS to correct volume depletion and hypoglycemia.
- Mineralocorticoids: Fludrocortisone is generally not needed acutely if stress doses of hydrocortisone are given (> 50 mg/day of hydrocortisone provides sufficient mineralocorticoid activity), but may be required for long-term maintenance in primary adrenal insufficiency once hydrocortisone doses are tapered.
A 48-year-old female is admitted to the ICU with a diagnosis of Diabetic Ketoacidosis (DKA). Her initial laboratory values are: Glucose 550 mg/dL, pH 7.15, Bicarbonate 10 mEq/L, and Potassium 2.9 mEq/L. She is receiving a 1 L bolus of normal saline. What is the most appropriate next step in her management?
A patient with a history of Graves' disease is admitted to the ICU with suspected thyroid storm following an elective surgery. The physician plans to order propylthiouracil (PTU), potassium iodide (Lugol's solution), propranolol, and hydrocortisone. Which of the following describes the correct sequencing and rationale for these medications?
A 65-year-old male with a history of hypothyroidism presents to the ED in the winter with profound lethargy, a core temperature of 33.5°C, a heart rate of 42 bpm, and a blood pressure of 75/40 mmHg. A diagnosis of myxedema coma is made. Alongside supportive care and passive rewarming, what is a critical pharmacological principle in his management?